A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma
M Tagliamento, P Bironzo, H Curcio, E De Luca… - Critical Reviews in …, 2022 - Elsevier
Introduction Advanced stage malignant mesothelioma (asMM) patients have poor prognosis.
Several trials investigated the role of programmed cell death protein-1 (PD-1) and its ligand …
Several trials investigated the role of programmed cell death protein-1 (PD-1) and its ligand …
Surgically targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review
Y Odia, AN Gutierrez, R Kotecha - Neuro-oncology, 2022 - academic.oup.com
The mainstays of radiation therapy include external beam radiation therapy (EBRT) and
internally implanted radiation, or brachytherapy (BT), all with distinct benefits and risks in …
internally implanted radiation, or brachytherapy (BT), all with distinct benefits and risks in …
Immune checkpoint inhibitors in malignant pleural mesothelioma: a systematic review and meta-analysis
Simple Summary Many clinical trials have investigated the role of Immune Checkpoint
Inhibitors (ICIs) in pleural mesothelioma (PM), with contrasting results. We performed a …
Inhibitors (ICIs) in pleural mesothelioma (PM), with contrasting results. We performed a …
Establishment and validation of nomograms to predict survival probability of advanced malignant pleural mesothelioma based on the SEER database and a Chinese …
X Zhang, L Chang, Y Zhu, Y Mao, T Zhang… - Frontiers in …, 2023 - frontiersin.org
Objective The purpose of this study was to build nomograms for predicting the survival of
individual advanced pleural mesothelioma (MPM) patients using the Surveillance …
individual advanced pleural mesothelioma (MPM) patients using the Surveillance …
Feasibility of tumor treating fields with pemetrexed and platinum-based chemotherapy for unresectable malignant pleural mesothelioma: Single-center, real-world data
T Kutuk, H Appel, MC Avendano, F Albrecht, P Kaywin… - Cancers, 2022 - mdpi.com
Simple Summary Management of malignant pleural mesothelioma (MPM) is challenging as
patients frequently present with unresectable disease and the response rates with systemic …
patients frequently present with unresectable disease and the response rates with systemic …
[PDF][PDF] Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma: a meta-analysis
Immune- Checkpoint Inhibitors in Malignant Pleural Mesothelioma: a meta-analysis Page 1 Page
1/16 Immune- Checkpoint Inhibitors in Malignant Pleural Mesothelioma: a meta-analysis Maria …
1/16 Immune- Checkpoint Inhibitors in Malignant Pleural Mesothelioma: a meta-analysis Maria …